NO20026286D0 - Nye peptider - Google Patents
Nye peptiderInfo
- Publication number
- NO20026286D0 NO20026286D0 NO20026286A NO20026286A NO20026286D0 NO 20026286 D0 NO20026286 D0 NO 20026286D0 NO 20026286 A NO20026286 A NO 20026286A NO 20026286 A NO20026286 A NO 20026286A NO 20026286 D0 NO20026286 D0 NO 20026286D0
- Authority
- NO
- Norway
- Prior art keywords
- new peptides
- growth factor
- vascular endothelial
- endothelial growth
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20026286A NO20026286D0 (no) | 2002-12-30 | 2002-12-30 | Nye peptider |
JP2004563063A JP2006523608A (ja) | 2002-12-30 | 2003-12-29 | Vegf及びvegfr−2のヘパリン結合ドメインに結合するペプチド |
AU2003288810A AU2003288810A1 (en) | 2002-12-30 | 2003-12-29 | Peptides that bind to the heparin binding domian of vegf and vegfr-2 |
EP03781116A EP1578785B1 (en) | 2002-12-30 | 2003-12-29 | Peptides that bind to the heparin binding domain of vegf and vegfr-2 |
US10/540,431 US20060089307A1 (en) | 2002-12-30 | 2003-12-29 | Peptides that bind to the heparin binding domian of vegf and vegfr-2 |
DE60319135T DE60319135D1 (de) | 2002-12-30 | 2003-12-29 | Peptide, die die heparinbindungsdomäne von vegf und vegfr-2 binden |
AT03781116T ATE386050T1 (de) | 2002-12-30 | 2003-12-29 | Peptide, die die heparinbindungsdomäne von vegf und vegfr-2 binden |
PCT/NO2003/000444 WO2004058802A1 (en) | 2002-12-30 | 2003-12-29 | Peptides that bind to the heparin binding domian of vegf and vegfr-2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20026286A NO20026286D0 (no) | 2002-12-30 | 2002-12-30 | Nye peptider |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20026286D0 true NO20026286D0 (no) | 2002-12-30 |
Family
ID=19914347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20026286A NO20026286D0 (no) | 2002-12-30 | 2002-12-30 | Nye peptider |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060089307A1 (no) |
EP (1) | EP1578785B1 (no) |
JP (1) | JP2006523608A (no) |
AT (1) | ATE386050T1 (no) |
AU (1) | AU2003288810A1 (no) |
DE (1) | DE60319135D1 (no) |
NO (1) | NO20026286D0 (no) |
WO (1) | WO2004058802A1 (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7666979B2 (en) * | 2002-03-01 | 2010-02-23 | Bracco International B.V. | Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same |
US8623822B2 (en) * | 2002-03-01 | 2014-01-07 | Bracco Suisse Sa | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
US7211240B2 (en) | 2002-03-01 | 2007-05-01 | Bracco International B.V. | Multivalent constructs for therapeutic and diagnostic applications |
WO2004065621A1 (en) | 2002-03-01 | 2004-08-05 | Dyax Corp. | Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
US7794693B2 (en) * | 2002-03-01 | 2010-09-14 | Bracco International B.V. | Targeting vector-phospholipid conjugates |
US7985402B2 (en) | 2002-03-01 | 2011-07-26 | Bracco Suisse Sa | Targeting vector-phospholipid conjugates |
CA2583399A1 (en) * | 2004-10-14 | 2006-04-27 | Sopherion Therapeutics, Inc. | Anti-angiogenic peptides and methods of use thereof |
US8236283B2 (en) | 2005-01-06 | 2012-08-07 | Ge Healthcare As | Optical imaging |
US9815867B2 (en) | 2012-09-03 | 2017-11-14 | The University Of Tokyo | Peptide for inhibiting vascular endothelial growth factor receptor |
KR101531944B1 (ko) * | 2013-12-24 | 2015-06-29 | 광주과학기술원 | Vegf에 특이적으로 결합하는 vegf-bpb |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6255458B1 (en) * | 1990-08-29 | 2001-07-03 | Genpharm International | High affinity human antibodies and human antibodies against digoxin |
US5928900A (en) * | 1993-09-01 | 1999-07-27 | The Rockefeller University | Bacterial exported proteins and acellular vaccines based thereon |
US6140470A (en) * | 1995-06-30 | 2000-10-31 | Yale University | Human monoclonal anti-tumor antibodies |
US5948667A (en) * | 1996-11-13 | 1999-09-07 | Her Majesty The Queen In Right Of Canada, As Represented By The Department Of Agriculture And Agri-Food | Xylanase obtained from an anaerobic fungus |
CA2301500A1 (en) * | 1997-08-27 | 1999-03-04 | Pioneer Hi-Bred International, Inc. | Genes encoding enzymes for lignin biosynthesis and uses thereof |
US7064193B1 (en) * | 1997-09-17 | 2006-06-20 | The Walter And Eliza Hall Institute Of Medical Research | Therapeutic molecules |
AU757554B2 (en) * | 1998-02-11 | 2003-02-27 | Bracco International B.V. | Angiogenesis targeting molecules |
US7045133B2 (en) * | 2000-01-18 | 2006-05-16 | Ludwig Institute For Cancer Research | VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor |
AU2001233277B2 (en) * | 2000-02-03 | 2004-06-03 | Millennium Pharmaceuticals, Inc. | Humanized anti-ccr2 antibodies and methods of use therefor |
CA2327208A1 (en) * | 2000-11-30 | 2002-05-30 | The Government Of The United States Of America | Methods of increasing distribution of therapeutic agents |
EP1469887A4 (en) * | 2001-07-20 | 2006-01-11 | Eidgenoess Tech Hochschule | COMPOSITIONS AND METHODS FOR USE AS BIOACTIVE AGENTS OF SULFATED AND SULFONATED AMINO ACIDS |
AU2003213730A1 (en) * | 2002-03-01 | 2003-09-16 | Bracco International B.V. | Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
-
2002
- 2002-12-30 NO NO20026286A patent/NO20026286D0/no unknown
-
2003
- 2003-12-29 JP JP2004563063A patent/JP2006523608A/ja active Pending
- 2003-12-29 WO PCT/NO2003/000444 patent/WO2004058802A1/en active IP Right Grant
- 2003-12-29 US US10/540,431 patent/US20060089307A1/en not_active Abandoned
- 2003-12-29 AT AT03781116T patent/ATE386050T1/de not_active IP Right Cessation
- 2003-12-29 AU AU2003288810A patent/AU2003288810A1/en not_active Abandoned
- 2003-12-29 DE DE60319135T patent/DE60319135D1/de not_active Expired - Lifetime
- 2003-12-29 EP EP03781116A patent/EP1578785B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20060089307A1 (en) | 2006-04-27 |
EP1578785B1 (en) | 2008-02-13 |
AU2003288810A1 (en) | 2004-07-22 |
ATE386050T1 (de) | 2008-03-15 |
EP1578785A1 (en) | 2005-09-28 |
JP2006523608A (ja) | 2006-10-19 |
WO2004058802A1 (en) | 2004-07-15 |
DE60319135D1 (de) | 2008-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
DE60028970D1 (de) | An her2 bindende peptidverbindungen | |
ATE394121T1 (de) | Verwendung von antikörpern gegen das muc18- antigen | |
PT1187918E (pt) | Antagonistas de tek | |
DE60220719D1 (de) | Antikörper gegen das muc18-antigen | |
EP1767544A3 (en) | Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 | |
EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
EP2447280A3 (en) | VEGF analogs and methods of use | |
DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
EA201100694A1 (ru) | Антитело к cd38 человека и его применение | |
EA201070636A1 (ru) | Ингибирование рецептора белка, стимулирующего макрофаги (ron), и способы его лечения | |
MA27880A1 (fr) | Derives de tetrahydrocarbazole et leur utilisation pharmaceutique | |
NO20026286D0 (no) | Nye peptider | |
EA200601217A1 (ru) | Новые конденсированные пирролокарбазолы | |
WO2004058803A3 (en) | Peptides that bind of the vegfr-2 | |
ATE402958T1 (de) | Antagonisten des ige-rezeptors | |
NO20060781L (no) | Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser | |
ATE480552T1 (de) | Stq-peptide | |
DE60312684D1 (de) | Plazenta-wachstumsfaktor als target für die behandlung von osteoporose | |
DE602004019541D1 (de) | Cycloalkyläbü kondensierte indole | |
ATE546154T1 (de) | Anti-angiogenetisches mittel und seine verwendung bei der krebsbehandlung | |
ATE324905T1 (de) | Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall | |
DK1581560T3 (da) | Anti-idiotypiske antistoffer mod faktor-VIII inhibitor og anvendelser deraf | |
WO2023166318A3 (en) | Therapeutic antibodies | |
ATE454144T1 (de) | Behandlung von malignen neoplasien |